Expanding Treatment Options for Patients in Need
Supporting Global Access to Essential Medications
At PharmaTurca, we understand the importance of ensuring patients have access to the medications they need, regardless of location. We specialize in exporting licensed pharmaceuticals, working with international partners to expand treatment options around the world.
Facilitating Managed Access Programs (MAPs)
Managed Access Programs (MAPs), also known as Expanded Access Programs (EAPs), Early Access Programs, Compassionate Use Programs, or Named Patient Programs (NPPs), play a crucial role in providing access to innovative treatments. We support these programs by supplying licensed medications to patients who have exhausted all approved options in their local market. This is particularly relevant for oncology and rare disease medications that might not yet be widely available.
Our Expertise in Global Logistics
As a leading pharmaceutical exporter with a global network, PharmaTurca offers a comprehensive solution for facilitating MAPs. We leverage our expertise in navigating complex international regulations and temperature-controlled logistics to ensure safe and timely delivery of these critical medications.
Partnering for Patient Care
We believe in fostering strong partnerships with healthcare professionals worldwide. By working together, we can ensure patients have access to the licensed medications they need while navigating the complexities of MAPs. Our commitment extends beyond just supplying medications; we offer transparent pricing models and ensure all our services comply with the highest regulatory standards.